术中激光辅助吲哚菁绿成像可降低显微乳房再造脂肪坏死率
结果显示吲哚菁绿组脂肪坏死发生率为3.4%(2/58),显著低于标准清创组的22.8%(18/79),比值比为0.11(95%CI 0.02-0.60,P=0.011)。结论认为术中吲哚菁绿血管造影与脂肪坏死风险显著降低相关。
要点
- 协议化吲哚菁绿引导皮瓣清创可使脂肪坏死风险显著降低。
- 吲哚菁绿组脂肪坏死率为3.4%,标准清创组为22.8%。
- 两组其他并发症无显著差异,证据等级为治疗性III级。
核心结论
- 术中吲哚菁绿血管造影与显微乳房再造术后脂肪坏死风险显著降低相关。
- 该技术可能减少额外修整手术并提高患者满意度。
- 尚需进一步研究评估其成本效益及在全部自体乳房再造人群中的普适性。
研究设计与样本
- 回顾性研究,比较协议化吲哚菁绿引导皮瓣清创实施前后两个队列。
- 采用多变量分析确定队列间显著差异及脂肪坏死的有意义变化。
主要发现
- 两组间皮瓣类型是唯一显著差异,吲哚菁绿组更可能为DIEP皮瓣(43.1% vs 25.3%,p=0.038)。
- 总体术后脂肪坏死发生率为14.6%(20/137个皮瓣)。
- 标准清创组脂肪坏死为18/79个皮瓣(22.8%),吲哚菁绿组为2/58个皮瓣(3.4%)。
- 比值比为0.11(95%CI 0.02-0.60,p=0.011)。
- 其他并发症特征无显著差异。
关键数值与推荐
- 总体脂肪坏死发生率14.6%(20/137个皮瓣)。
- 标准清创组脂肪坏死率22.8%(18/79个皮瓣)。
- 吲哚菁绿引导清创组脂肪坏死率3.4%(2/58个皮瓣)。
- 比值比0.11(95%CI 0.02-0.60,p=0.011)。
- 证据等级:治疗性,III级。
临床怎么用
- 可在显微乳房再造术中采用协议化吲哚菁绿血管造影评估皮瓣灌注。
- 依据灌注情况指导低灌注组织的合理切除。
- 该技术可能减少脂肪坏死相关修整手术。
局限性
- 回顾性研究设计。
- 两组间皮瓣类型存在显著差异。
- 成本效益及普适性尚需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fat necrosis following microsurgical breast reconstruction is common and problematic for patients and surgeons alike. Indocyanine green angiography provides a means of evaluating flap perfusion at the time of surgery to inform judicious excision of hypoperfused tissue. The authors hypothesized that incorporation of protocolized indocyanine green-informed flap débridement at the time of surgery would decrease the incidence of fat necrosis. METHODS: A retrospective study of two cohorts was performed evaluating patients before and after implementation of protocolized indocyanine green-guided flap excision. Variables included demographics, procedural details, and complications. Multivariable analysis was used to determine significant differences between the cohorts and evaluate for meaningful changes in fat necrosis. RESULTS: Eighty patients were included, accounting for 137 flaps. Flap type was the only significant difference between the two groups, with the indocyanine green group more likely to be deep inferior epigastric perforator flaps (43.1 percent versus 25.3 percent; p = 0.038). The overall postoperative incidence of fat necrosis was 14.6 percent (20 of 137 flaps). Comparing by cohort, the standard débridement group showed 18 of 79 flaps with fat necrosis (22.8 percent), whereas the indocyanine green-informed débridement group showed only two of 58 flaps with fat necrosis (3.4 percent; odds ratio, 0.11; 95 percent CI, 0.02 to 0.60; p = 0.011). There were no other significant differences in complication profile. CONCLUSIONS: Intraoperative use of indocyanine green angiography was associated with significantly lower odds of fat necrosis. This technology may reduce additional revision operations and improve patient satisfaction. Additional studies are needed to determine whether this innovation is cost-effective and generalizable to the entire autologous breast reconstruction population. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Momeni A, Sheckter C. Intraoperative Laser-Assisted Indocyanine Green Imaging Can Reduce the Rate of Fat Necrosis in Microsurgical Breast Reconstruction. Plast Reconstr Surg. 2020. PMID: 32097299. doi:10.1097/PRS.0000000000006547
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。